Hot Papers

D. Kim, D.L. Lewis, L. Graziadei, E.J. Neer, D. Bar-Sagi, D.E. Clapham, "G-protein áç-subunits activate the cardiac muscarinic K+-channel via phospholipase A2," Nature, 337, 557-60, 9 February 1989. David Clapham (Mayo Foundation, Rochester, Minn.): "More than 70 (for example, à,á, muscarinic, and rhodopsin) receptor types are linked to their effectors via G proteins. These G proteins are composed of two functional subunits, known as Gà and Gáà. Although the e


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

D. Kim, D.L. Lewis, L. Graziadei, E.J. Neer, D. Bar-Sagi, D.E. Clapham, "G-protein áç-subunits activate the cardiac muscarinic K+-channel via phospholipase A2," Nature, 337, 557-60, 9 February 1989. David Clapham (Mayo Foundation, Rochester, Minn.): "More than 70 (for example, à,á, muscarinic, and rhodopsin) receptor types are linked to their effectors via G proteins. These G proteins are composed of two functional subunits, known as Gà and Gáà. Although the evidence that the Gà subunit activates effectors is well known, we proposed in an earlier paper that in some cases the Gáà subunit may also activate an effector, the cardiac muscarinic-gated potassium channel (Logothetis, et al., Nature, 325: 321-6, 1987). This idea was controversial, since most evidence supports Gáà's main role to be as an inhibitor of Gà. This paper proposed that Gáà activates the cardiac potassium channel via stimulation of phospholipase A2 and subsequent generation of arachidonic acid and its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo